Loading organizations...
Loading organizations...
Gene therapy company addressing manufacturing challenges for rare blindness
Opus Genetics has raised $19.0M across 1 funding round.
Opus Genetics has raised $19.0M in total across 1 funding round.
Opus Genetics has raised $19.0M in total across 1 funding round.
Opus Genetics's investors include Peter Ginsberg, Bios Partners, Paul Manning.
Opus Genetics has raised $19.0M across 1 funding round. Most recently, it raised $19.0M Seed in September 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 22, 2021 | $19.0M Seed | Peter Ginsberg | Bios Partners, Paul Manning |